Lupin had earlier signed a licensing agreement with Pfizer Inc for Celebrex, which has an annual sales of $ 2.54 billion in US market, it a...

The company has also received tentative approvals for its product in strengths of 100 mg, 200 mg and 400 mg from the FDA.

The drug is an anti-infective agent used to treat a variety of bacterial and protozoal infections.